Table_2_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.XLSX by Anna L. Engelbrektson (5560358)

“…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”

The Potential of Antimicrobials to Induce Thrombocytopenia in Critically Ill Patients: Data from a Randomized Controlled Trial by Maria Egede Johansen (490779)

CsEVs activated BECs TLR3 and regulated the hyperphosphorylation of p38 and ERK to reduce IL-6 and TNF expression. by Yuru Wang (846969)

The future forecasts of GBD in RB. by SiQi Zhang (1559509)

“…</p><p>Results</p><p>The global number of RB cases in children under 10 years of age in 2021 was 57,333 (95%UI: 34339.65,761.03), the annual standardized prevalence rate (ASPR) was 4.39(95%UI: 2.63, 5.95), and the AAPC (1990−2021) was 0.65(95%CI: 0.44, 0.86). …”

G1 cell cycle arrest and sub-G1 population induced by bortezomib/venetoclax were stronger in sLCL expressing BHRF-1, EBNA-3C, LMP-1 and NOXA. by Kam Pui Tam (19746865)

List of excluded articles. by Yasmine Makhlouf (17409866)

Poly (I:C) intervention reduced myofibroblast activation and collagen fibrosis deposition in <i>C</i>. by Yuru Wang (846969)

Average velocity of tensile sample. by Chaojie Zhao (11467197)

DataSheet1_Resveratrol has an Overall Neuroprotective Role in Ischemic Stroke: A Meta-Analysis in Rodents.docx by Jianyang Liu (9632387)

“…Quality assessment was performed using a 10-item checklist. Studies quality scores ranged from 3 to 8, with a mean value of 5.94. …”

DataSheet_1_Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectom... by Wenjie Ni (6472181)

“…</p>Materials and methods<p>Post hoc analysis was conducted on data from 116 patients with esophageal cancer from a randomized controlled trial comparing adjuvant therapy with surgery alone. …”

Validation analyses with multiple cohorts of datasets and characterization of genes located in regions with predicted CNV events. by Deng Wu (805710)

Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models by Joseph B. Sempa (7861247)

“…An increase in cumulative log viral load is associated with a decrease in CD4 count slope (19.6 cells/μL (95% credible interval: 28.26, 10.93)) and a reduction in the odds of achieving a CD4 counts ≥500 cells/μL (0.42 (95% CI: 0.236, 0.730)) during 5 years of therapy. …”

IR-induced mutation profiles of DNA repair mutants significantly different from wild-type. by Bettina Meier (274833)

Relationships between hardness and IDDSI levels. by Muxi Chen (9294270)

Schematic flow of study participants. by Sangmi Lee (3447803)

Effects of alcohol on bone morphology and alcohol metabolism ability in female and male rats. by Ming Cheng (494553)

“…Green arrows indicate thinning of bone trabecula, yellow arrows indicate decreased bone marrow hematopoietic cells. Scale bar: 50 μm, 400 × . …”

Downregulation of the ouabain-sensitive (Na⁺+K⁺)ATPase from renal proximal tubule cells of chronically undernourished rats. by Amaury Pereira-Acácio (591234)

Effects of head motion parameters on developmental changes of nodal entropy. by Tianyuan Lei (19683861)

HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy by Davide Croce (383177)

“…From an economic point of view, the CP implementation led to a substantial advantage: the mean total costs related to the management of the HIV disease (ART, hospital admission and laboratory tests) decreased (-8.60%) in the Post-CP phase (p-value < 0.0001). …”

The APPLe Study: A Randomized, Community-Based, Placebo-Controlled Trial of Azithromycin for the Prevention of Preterm Birth, with Meta-Analysis by Nynke R. van den Broek (248401)

“…There were no significant differences in outcome between the azithromycin group (<em>n</em> = 1,096) and the placebo group (<em>n</em> = 1,087) in respect of preterm birth (16.8% versus 17.4%), odds ratio (OR) 0.96, 95% confidence interval (0.76–1.21); mean gestational age at delivery (38.5 versus 38.4 weeks), mean difference 0.16 (−0.08 to 0.40); mean birthweight (3.03 versus 2.99 kg), mean difference 0.04 (−0.005 to 0.08); perinatal deaths (4.3% versus 5.0%), OR 0.85 (0.53–1.38); or maternal malarial parasitaemia (11.5% versus 10.1%), OR 1.11 (0.84–1.49) and anaemia (44.1% versus 41.3%) at 28–32 weeks, OR 1.07 (0.88–1.30). …”